adult lymphocyte depletion Hodgkin lymphoma
Showing 1 - 25 of >10,000
Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin
Completed
- Adult Lymphocyte Depletion Hodgkin Lymphoma
- +5 more
- gemcitabine hydrochloride
- bendamustine hydrochloride
-
Atlanta, Georgia
- +1 more
Oct 21, 2021
Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin
Active, not recruiting
- Adult Lymphocyte Depletion Hodgkin Lymphoma
- +16 more
- 6,8-bis(benzylthio)octanoic acid
- bendamustine hydrochloride
-
Winston-Salem, North Carolina
- +1 more
Apr 8, 2022
Quality of Life in Adult and Pediatric Nodular
Recruiting
- Nodular Lymphocyte-Predominant Hodgkin Lymphoma
-
Aurora, Colorado
- +1 more
Oct 27, 2023
Social and Genetic Factors on Outcomes in Adolescent and Young
Not yet recruiting
- Hodgkin Lymphoma
- Non-Hodgkin Lymphoma
- Biospecimen Collection
- +2 more
- (no location specified)
Aug 18, 2023
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia Trial (Miltenyi CliniMACS Prodigy ®
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +6 more
- Miltenyi CliniMACS Prodigy ® system
- (no location specified)
Mar 23, 2023
Non-hodgkin Lymphoma,B Cell Trial (CD19-targeted non-viral PD1 site-specific integrated CAR-T cell injection)
Not yet recruiting
- Non-hodgkin Lymphoma,B Cell
- CD19-targeted non-viral PD1 site-specific integrated CAR-T cell injection
- (no location specified)
Feb 14, 2023
Nodular Lymphocyte Predominant Hodgkin Lymphoma, Recurrent Nodular Lymphocyte Predominant Hodgkin Lymphoma, Refractory Nodular
Not yet recruiting
- Nodular Lymphocyte Predominant Hodgkin Lymphoma
- +2 more
- Biopsy
- +9 more
- (no location specified)
Jun 1, 2023
Leukemia, Stem Cell Transplantation Trial in Munich (FBTA05)
Withdrawn
- Leukemia
- Stem Cell Transplantation
-
Munich, Bavaria, Germany3. Medizinische Klinik, Klinikum rechts der Isar der TU München
Dec 5, 2022
Relapsed or Refractory Non-Hodgkin's Lymphoma Trial in China (AXT-1003)
Not yet recruiting
- Relapsed or Refractory Non-Hodgkin's Lymphoma
-
Beijing, China
- +3 more
Jul 20, 2023
Hodgkin Lymphoma Trial in Latakia (First analysis: Lymphocyte count > or = 1500 cells per microlitre, second analysis: IPS < 3
Recruiting
- Hodgkin Lymphoma
- First analysis: Lymphocyte count > or = 1500 cells per microlitre, second analysis: IPS < 3 and third analysis: Lymphocyte/Monocyte ratio > or = 2.9
- First analysis: Lymphocyte count < 1500 cells per microlitre, second analysis: IPS > or = 3 and third analysis: Lymphocyte/Monocyte ratio < 2.9
-
Latakia, Syrian Arab RepublicTishreen University
Feb 14, 2022
Relapsed or Refractory B Cell Non-Hodgkin Lymphoma Trial (C-CAR066)
Not yet recruiting
- Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
- (no location specified)
Mar 23, 2023
Immunogenicity of COVID-19 Vaccinations in Autologous HSCT
Not yet recruiting
- COVID-19
- +2 more
-
Cologne, NRW, GermanyUniversity Hospital of Cologne
Oct 27, 2022
Mature B-Cell Non-Hodgkin Lymphoma Trial (Obinutuzumab, Glofitamab, Rituximab)
Not yet recruiting
- Mature B-Cell Non-Hodgkin Lymphoma
- Obinutuzumab
- +6 more
- (no location specified)
Sep 6, 2022
Advanced or Metastatic Solid Tumors, Non-Hodgkin Lymphoma Trial in San Antonio (WTX-330)
Recruiting
- Advanced or Metastatic Solid Tumors
- Non-Hodgkin Lymphoma
-
San Antonio, TexasNEXT Oncology
Jan 6, 2023
B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Charleston (Cyclophosphamide injection, Fludarabine
Not yet recruiting
- B-cell Non Hodgkin Lymphoma
- Chronic Lymphocytic Leukemia
- Cyclophosphamide injection
- +2 more
-
Charleston, South CarolinaHollings Cancer Center at Medical University of South Carolina
Jan 18, 2023
Refractory Non Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma Trial in Sacramento (biological, radiation, procedure, drug)
Active, not recruiting
- Refractory Non Hodgkin Lymphoma
- Relapsed Non Hodgkin Lymphoma
- rituximab
- +7 more
-
Sacramento, CaliforniaUniversity of California Davis
Nov 28, 2022
Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, MALT Trial in Duarte (biological, procedure,
Active, not recruiting
- Adult Grade III Lymphomatoid Granulomatosis
- +23 more
- autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 4, 2023
Non-hodgkin Lymphoma, Acute Lymphoblastic Leukaemia, Chronic Lymphocytic Leukemia Trial in Tianjin (CC312)
Recruiting
- Non-hodgkin Lymphoma
- +2 more
- CC312
-
Tianjin, Tianjin, ChinaInstituteHBDH
Sep 12, 2023
Non Hodgkin Lymphoma Trial in Aurora (UCD19 CAR T Cells)
Active, not recruiting
- Non Hodgkin Lymphoma
- UCD19 CAR T Cells
-
Aurora, ColoradoUniversity of Colorado Hospital
Sep 1, 2022
Hodgkin Lymphoma, Refractory Hodgkin Lymphoma, Relapsed Hodgkin's Disease, Adult Trial in Leon (Brentuximab Vedotin 50 MG
Recruiting
- Hodgkin Lymphoma
- +2 more
- Brentuximab Vedotin 50 MG [Adcetris]
-
Leon, Guanajuato, MexicoHospital Regional Alta Especialidad Bajio
Oct 24, 2022
Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin
Unknown status
- Adult Lymphocyte Depletion Hodgkin Lymphoma
- +6 more
- brentuximab vedotin
- +11 more
-
Stanford, California
- +6 more
Feb 14, 2020
B Cell Non-Hodgkin's Lymphoma Trial in Duarte (CD19/CD20-directed CAR-T cells)
Recruiting
- B Cell Non-Hodgkin's Lymphoma
- CD19/CD20-directed CAR-T cells
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 10, 2022